Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583050 · ClinicalTrials.gov registry record · NA
Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,366
- Enrollment target
NCT00583050: Completed NA study, sponsored by The Cleveland Clinic.
NCT00583050 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 1,366 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00583050, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,366 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the role of fenestrated/branched stent-grafts in the exclusion of abdominal aortic and thoracoabdominal aneurysms.
Primary Outcome
Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan
Interventions
- DEVICE Endovascular Aneurysm Repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,366 participants |
| Start Date | 2001-02 |
| Est. Completion | 2020-02-01 |
| Phase | NA |
What the finished NCT00583050 record still lists
NCT00583050 is an interventional study that assigns participants to a tested intervention. Its 1,366 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Endovascular Aneurysm Repair is the first listed.
NCT00583050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00583050 about?
NCT00583050 is a clinical study titled "Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts". The purpose of the study is to evaluate the role of fenestrated/branched stent-grafts in the exclusion of abdominal aortic and thoracoabdominal aneurysms.
What is the current status of trial NCT00583050?
This trial is currently completed. It is a NA study. The enrollment target is 1,366 participants. The study started on 2001-02. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT00583050?
The interventions under investigation include: Endovascular Aneurysm Repair (DEVICE).
Who is sponsoring clinical trial NCT00583050?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00583050's enrollment target sits among peer trials
1,366 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia